References
- 1. F. Amant, E. Steenkiste, K. Schurmans, et al. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma. Int J Gynecol Cancer, 14 (2004), pp. 1118–21.
- 2. D’Angelo E, Prat J. Pathology of mixed Müllerian tumours. Best Pract Res Clin Obstet Gynaecol. 2011 Dec;25(6):705-18.10.1016/j.bpobgyn.2011.05.010
- 3. Chaudhary YS, Illahi F, Moatasim A. Carcinosarcoma uterine unusual histologic presentation. Rawal Med J 2009;34:120-2
- 4. Kuyumcuoglu U, Kale A. Homologous type malignant mixed Mullerian tumour of the uterus presenting as cervical mass. J Chin Med Assoc 2009;72:533-51983764810.1016/S1726-4901(09)70423-X
- 5. Yildirim Y, Inal MM, Sanci M, Yildrim YK, Mit T, Polat M, et al. Development of uterine sarcoma after tamoxifen treatment for breast cancer: A report four cases. Int J Gynecol Cancer 2005;15:1239-4210.1111/j.1525-1438.2005.00170.x
- 6. Wolfson AH, Wolfson DH, Sittler SY, Breton L, Markoe AM, Schwade JG, et al. A multivariate analysis of clinicopathologic factors for predicting outcome in uterine sarcomas. Gynecol Oncol 1994;52:56-62
- 7. Philip CA1, Pautier P, Duffaud F, Ray-Coquard I. High-grade undifferentiated sarcomas of the uterus: diagnosis, outcomes, and new treatment approaches. CurrOncolRep. 2014Oct;16(10):405
- 8. Seagle BL1, Sobecki-Rausch J2, Strohl AE2, Shilpi A2, Grace A2, Shahabi S2 Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study Gynecol Oncol. 2017 Apr;145(1):61-70.
- 9. Vasconcelos AL1, Nunes B1, Duarte C1, Mendonça V1, Ribeiro J2, Jorge M1, Monteiro Grillo I3 Tamoxifen in breast cancer ipse dixit in uterine malignant mixed Müllerian tumor and sarcoma-A report of 8 cases and review of the literature. Rep Pract Oncol Radiother. 2013 Aug 12;18(5):251-60
- 10. Katedra za Ginekologiju I akušerstvo, Medicinski fakultet Beograd, Ginekologija I akušerstvo, 2005, Februar, 144-145